Connect Biopharma Holdings Net Debt Growth & History (CNTB)

Connect Biopharma Holdings's net debt was −$37.7M for fiscal 2025.

View full Connect Biopharma Holdings company overview

Connect Biopharma Holdings annual net debt history

Connect Biopharma Holdings annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31−$37.7M$40.4M
20242024-12-31−$78.1M$26.7M
20232023-12-31−$104.7M−$26.2M
20222022-12-31−$78.5M$189.1M
20212021-12-31−$267.6M

Connect Biopharma Holdings net debt trends

Between the periods ended 2021-12-31 and 2025-12-31, Connect Biopharma Holdings's net debt increased from −$267.6M to −$37.7M, a change of $229.9M. The latest reported quarter, Q2 2026, shows −$26.4M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Connect Biopharma Holdings source filings ↗

Community posts

It’s quiet here.

No posts about CNTB yet. Start the conversation.

Write the first post